From 1990 to 2019, the ASIR of prostate cancer in high SDI regions each year was greatly higher than that in the other SDI regions, which could be a result of the broadened prostate-specific antigen (PSA) screening for prostate cancer in developed countries that started in the 1990s (13). This evidence concerns the gene KLK3 and prostate cancer.